Abstract: According to various embodiments, a LIDAR system (100) may have: a detector (104) having a plurality of detector pixels (106) arranged along a first direction, wherein each detector pixel (106) of the plurality of detector pixels (106) is assigned to a respective sub-section of the field of view (102); a light source (110) having a plurality of sub-light sources (112) arranged along a second direction at an angle to the first direction, wherein each sub-light source (112) of the plurality of sub-light sources (112) is assigned to a respective sub-section of the field of view (102); a coarse angle control element (114) which is configured to deflect light from the light source (110) to the field of view and to deflect light from the field of view (102) to the detector (104); and a light emission controller (118) which is configured to control the sub-light sources (112) of the plurality of sub-light sources (112) in such a way that each sub-light source (112) of the plurality of sub-light sources (112) emits l

Abstract: It is described at least a method for performing vehicle operation analysis of a driver, comprising retrieving data related to the operation of the vehicle via a mobile device, wherein the mobile device is placed inside the vehicle and the retrieved data is data that is at least provided by data providing units included in the mobile device; adding a driver-specific identifier to the retrieved data which identifies the driver of the vehicle irrespective of the vehicle that is used; performing analysis of the retrieved data in the mobile device, and/or sending the retrieved data to a remote computer and performing analysis of said data in the remote computer, wherein the analysis includes extracting driver-specific vehicle operation schemes and/or calculating a driver-specific safety factor.

Abstract: The present invention is related to production of a sterol mix in a modified yeast cell, wherein the amount of zymosterol present in said mix is dramatically reduced or abolished via modification of sterol acyltransferase activity within said yeast. The modified yeast cell can be used for production of vitamin D3 or derivatives and/or metabolites thereof.

Abstract: A system for transmitting at least one upgrade package for at least one control device of a motor vehicle is provided. The system includes a storage device external to the motor vehicle that stores the upgrade package, as well as a communication device that wirelessly transmits the upgrade package from the storage device external to the motor vehicle to at least one transmission device of the system. The transmission device conducts a transmission process of the upgrade package for the at least one control device and installs the upgrade package on the at least one control device. The at least one transmission device is arranged internally in the motor vehicle.

Abstract: The present invention is related to production of a sterol mix in a modified yeast cell, wherein the amount of zymosterol present in said mix is dramatically reduced or abolished via modification of sterol acyltransferase activity within said yeast. The modified yeast cell can be used for production of vitamin D3 or derivatives and/or metabolites thereof.

Abstract: A system for transmitting at least one upgrade package for at least one control device of a motor vehicle is provided. The system includes a storage device external to the motor vehicle that stores the upgrade package, as well as a communication device that wirelessly transmits the upgrade package from the storage device external to the motor vehicle to at least one transmission device of the system. The transmission device conducts a transmission process of the upgrade package for the at least one control device and installs the upgrade package on the at least one control device. The at least one transmission device is arranged internally in the motor vehicle.

Abstract: The present invention relates to a novel and inventive process for the production of sorbitol from D-sucrose.

Abstract: The present invention provides an improved biotechnological production of riboflavin (also referred herein as vitamin B2) through modification in the operon containing the riboflavin biosynthetic genes (rib operon), in particular modifications of/in the leader sequences (rib leader) upstream of the corresponding riboflavin biosynthetic genes (rib operon). Furthermore, the present invention relates to genetically engineered microorganisms carrying said modified sequences, processes to generate said modified sequences/microorganisms and the use thereof for production of riboflavin.

Abstract: It is described at least a method for performing vehicle operation analysis of a driver, comprising retrieving data related to the operation of the vehicle via a mobile device, wherein the mobile device is placed inside the vehicle and the retrieved data is data that is at least provided by data providing units included in the mobile device; adding a driver-specific identifier to the retrieved data which identifies the driver of the vehicle irrespective of the vehicle that is used; performing analysis of the retrieved data in the mobile device, and/or sending the retrieved data to a remote computer and performing analysis of said data in the remote computer, wherein the analysis includes extracting driver-specific vehicle operation schemes and/or calculating a driver-specific safety factor.

Abstract: The present invention relates to a new process for the production of D-sorbitol.

Abstract: The present invention relates to a novel and inventive process for the production of sorbitol from D-sucrose.

Abstract: The present invention relates to a new process for the production of D-sorbitol.

Abstract: This invention relates to the production of 7-dehydrocholesterol, 25-hydroxy-7-dehydrocholesterol, and 25-hydroxy ergosterol in yeast such as Saccharomyces cerevisiae. It also relates to various enzymes catalyzing the reduction of the double bond at position 24 of lanosterol, dimethyl zymosterol, methyl zymosterol, zymosterol, cholesta-7, 24-dienol, or cholesta-5,7,24-trienol; or the hydroxylation at position 25 of ergosterol, 7-dehydrocholesterol, cholesta-8-enol, and cholesta-7-enol. It also relates to various nucleic acids encoding cholesterol C25-hydroxylases and sterol ?24-reductases and their use to produce and hydroxylate 7-dehydrocholesterol or ergosterol. It also relates to the yeast strains so produced, and methods of making these sterols that include the steps of cultivaton a transformed yeast cell, and harvesting the resulting sterol(s).

Abstract: The present invention relates to a improved process for the biotechnological production of compounds for which ribose-5-phosphate, ribulose-5-phosphate or xylulose-5-phosphate is biosynthetic precursor like riboflavin (vitamin B2), FAD, FMN, pyridoxal phosphate (vitamin B6), guanosine, GMP, adenosine, AMP. The invention further pertains to the generation of the organism producing those compounds. It furthermore relates to the generation of mutated transketolases that allow normal growth on glucose but reduced growth on gluconate when introduced into the production strains and to polynucleotides encoding them.

Abstract: The present invention is directed to novel genes mediating the carbon catabolite repression (CCR) of gluconeogenic genes. Furthermore, the polypeptides encoded by said genes as well as the use of said genes in a process for the production of a target fermentation product is provided. Processes for generating such microorganisms are also provided by the present invention. The invention is also related to a genetically engineered microorganism and its use for the production of a target fermentation product, wherein the gluconeogenic genes are relieved from CCR within said microorganism.

Abstract: The present invention relates to a improved process for the biotechnological production of compounds for which ribose-5-phosphate, ribulose-5-phosphate or xylulose-5-phosphate is biosynthetic precursor like riboflavin (vitamin B2), FAD, FMN, pyridoxal phosphate (vitamin B6), guanosine, GMP, adenosine, AMP. The invention further pertains to the generation of the organism producing those compounds. It furthermore relates to the generation of mutated transketolases that allow normal growth on glucose but reduced growth on gluconate when introduced into the production strains and to polynucleotides encoding them.

Abstract: This invention relates to the production of 7-dehydrocholesterol, 25-hydroxy-7-dehydrocholesterol, and 25-hydroxy ergosterol in yeast such as Saccharomyces cerevisiae. It also related to various enzymes catalyzing the reduction of the double bond at position 24 of lanosterol, dimethyl zymosterol, methyl zymosterol, zymosterol, cholesta-7, 24-dienol, or cholesta-5,7,24-trienol; or the hydroxylation at position 25 of ergosterol, 7-dehydrocholesterol, cholesta-8-enol, and cholesta-7-enol. It also relates to various nucleic acids encoding cholesterol C25-hydroxylases and sterol ?24-reductases and their use to produce and hydroxylate 7-dehydrocholesterol or ergosterol. It also relates to the yeast strains so produced, and methods of making these sterols comprising the steps of cultivation a transformed yeast cell, and harvesting the resulting sterol(s).

Abstract: The present invention relates to a improved process for the biotechnological production of compounds for which ribose-5-phosphate, ribulose-5-phosphate or xylulose-5-phosphate is biosynthetic precursor like riboflavin (vitamin B2), FAD, FMN, pyridoxal phosphate (vitamin B6), guanosine, GMP, adenosine, AMP. The invention further pertains to the generation of the organism producing those compounds. It furthermore relates to the generation of mutated transketolases that allow normal growth on glucose but reduced growth on gluconate when introduced into the production strains and to polynucleotides encoding them.

Abstract: The present invention provides an improved biotechnological production of riboflavin (also referred herein as vitamin B2) through modification in the operon containing the riboflavin biosynthetic genes (rib operon), in particular modifications of/in the leader sequences (rib leader) upstream of the corresponding riboflavin biosynthetic genes (rib operon). Furthermore, the present invention relates to genetically engineered microorganisms carrying said modified sequences, processes to generate said modified sequences/microorganisms and the use thereof for production of riboflavin.

Abstract: The present invention provides a process for producing a target fermentation product. This process includes providing a fermentation medium containing a recombinantly-produced microorganism that over-produces a fermentation product and contains a mutation which causes auxotrophic growth of the microorganism wherein the auxotrophy within the microorganism does not compromise the ability of the microorganism to produce the fermentation product. The medium is then supplied in excess with all substrates required for production of the fermentation product and in growth limiting amounts with a substrate complementing the auxotrophy. Host cells, vectors, and polynucleotide sequences used in the process are also provided. The polynucleotide sequences of the present invention include sequences derived from the biotin operon of B. subtilis and in particular the bioFDB gene cassette.